[4].《年轻乳腺癌诊疗与生育管理专家共识》 [5].Azim HA Jr, Kroman N, Paesmans M, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study[J]. J Clin Oncol, 20...
[4].《年轻乳腺癌诊疗与生育管理专家共识》 [5].Azim HA Jr, Kroman N, Paesmans M, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study[J]. J Clin Oncol, 2013, 31(1): 73‑79. [6].Lambertini M, Blondeaux...
Estrogen receptor (ER) positive patient derived xenograft (PDX) models of breast cancer are important translational tools in our pursuit for a better understanding of treatment resistance and for the preclinical evaluation of novel therapies. PDX modelling of ER+ breast cancer is traditionally ...
Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor-Positive Breast Cancers: Is It Prognostic?[J]. Clin Breast Cancer, 2021,21(1):e53-e62. [16] Wang C, Xu Y, Lin Y, et al. Comparison of CTS5 risk model and 21...
Estrogen receptor positive breast cancers and their association with environmental factorsdoi:10.1186/1476-072X-10-32Background Epidemiological studies to assess risk factors for breast cancer often do not differentiate between different types of breast cancers. We applied a general linear model to...
The long-sought discovery of HER2 as an actionable and highly sensitive therapeutic target was a major breakthrough for the treatment of highly aggressive HER2-positive breast cancer, leading to approval of the first HER2-targeted drug — the monoclonal
Estrogen receptor (ER) and progesterone receptor (PR) testing are performed in the evaluation of breast cancer. While the clinical utility of ER as a predictive biomarker to identify patients likely to benefit from hormonal therapy is well-established, t
Hormone Receptor-Positive Breast Cancer About 80% of allbreastcancers are “ER-positive.” That means thecancercells grow in response to the hormone estrogen. About 65% of these are also “PR-positive.” They grow in response to another hormone, progesterone. ...
乳腺癌目前是全球最常见的癌症,也是女性癌症死亡的主要原因。这种异质性疾病表型多样,包含几种行为和治疗反应各异的生物学亚型。其中最常见的类型为激素受体阳性,即雌激素受体(estrogen receptor, ER)和/或孕激素受体(progesterone receptor, PR)阳性乳腺癌,占所有乳腺癌病例的75%。
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science, 235 (1987), pp. 177-182 CrossrefGoogle Scholar [3] W.F. Anderson, N. Chatterjee, W.B. Ershler, O.W. Brawley Estrogen receptor breast cancer phenotypes in the surveillance, epidem...